Recombinant Human Syndecan-4 Protein

Syndecan-4 is a cell surface proteoglycan belonging to the syndecan family, which plays pivotal roles in various physiological and pathological processes, including cell adhesion, migration, and signaling. Given its involvement in wound healing, inflammation, and cancer metastasis, research has increasingly focused on Syndecan-4 as a potential therapeutic target. The extracellular part of Syndecan-4 serves as a co-receptor for various growth factors and cytokines, thereby influencing cellular responses to the extracellular matrix (ECM) and intercellular interactions. The production of recombinant Syndecan-4 proteins has enhanced our ability to study its biological functions and interactions in vitro and in vivo, providing insights into its mechanisms of action. Additionally, these recombinant proteins can be utilized to elucidate Syndecan-4's role in pathological conditions, potentially leading to the development of novel therapeutic strategies. Recent studies have indicated that modulating Syndecan-4 levels can impact tumor progression and immune responses, highlighting its significance in cancer biology and regenerative medicine. Thus, the development and characterization of Syndecan-4 recombinant proteins are crucial for advancing our understanding of its multifaceted roles in health and disease, paving the way for innovative treatments targeting this versatile proteoglycan.